CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.
Pancreatology
; 16(1): 115-20, 2016.
Article
in En
| MEDLINE
| ID: mdl-26613889
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Gene Expression Regulation, Neoplastic
/
CA-19-9 Antigen
/
CA-125 Antigen
/
Galectin 3
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Pancreatology
Journal subject:
ENDOCRINOLOGIA
/
GASTROENTEROLOGIA
Year:
2016
Type:
Article
Affiliation country:
France